Genomics of therapy-related myeloid neoplasms

• Teodora Kuzmanovic,
• Bhumika J. Patel,
• Srinivasa R. Sanikommu,
• Yasunobu Nagata,
• Hassan Awada,
• Cassandra M. Kerr,
• Bartlomiej P. Przychodzen,
• Babal K. Jha,
• Devendra Hiwase,
• Deepak Singhal,
• Anjali S. Advani,
• Aziz Nazha,
• Aaron T. Gerds,
• Hetty E. Carraway,
• Mikkael A. Sekeres,
• Sudipto Mukherjee,
• Jaroslaw P. Maciejewski,
• Tomas Radivoyevitch

Affiliations

Teodora Kuzmanovic

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Bhumika J. Patel

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Srinivasa R. Sanikommu

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Yasunobu Nagata

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Hassan Awada

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Cassandra M. Kerr

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Bartlomiej P. Przychodzen

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Babal K. Jha

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Devendra Hiwase

Department of Haematology, Royal Adelaide Hospital, Port Road, Adelaide, Australia

Deepak Singhal

Department of Haematology, Royal Adelaide Hospital, Port Road, Adelaide, Australia

Anjali S. Advani

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Aziz Nazha

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Aaron T. Gerds

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Hetty E. Carraway

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Mikkael A. Sekeres

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Sudipto Mukherjee

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Jaroslaw P. Maciejewski

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA;Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Tomas Radivoyevitch

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA;Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA